#214168

Electra Therapeutics to Highlight ELA026 in Three Presentations at the American Society of Hematology (ASH) 2022 Annual Meeting

By |2022-12-05T18:43:44-05:00November 3, 2022|Press Release|0 Comments
Read More

Electra Therapeutics announces $84 million Series B financing and unveils its novel SIRP targeted therapies for immunological diseases and cancer

Company’s first-in-class approach to targeting of signal regulatory proteins (SIRP) [...]

By |2022-12-05T18:44:13-05:00February 16, 2022|Press Release|0 Comments
Read More

Star Therapeutics emerges from stealth mode raising $100M in financing since inception to be an innovation engine for rare disease therapies

Drug discovery approach uncovers novel biology for treatments that can [...]

By |2022-12-05T18:39:45-05:00February 16, 2022|Press Release|0 Comments
Read More

© 2022 STAR Therapeutics Inc.

THANK YOU

We look forward to connecting with you